|
⚲
|
| Keyboard |
| Roche Holding Ltd
✚
|
|
|---|---|
| CIK # | 0000889131 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0000889131] | |
| 4 | [0000889131] | |
| SC 13D | [0000889131] | |
| SC 13G | [0000889131] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Roche Holding Ltd | Ignyta Inc | [2018-01-02] |
| Roche Holding Ltd | Senseonics Holdings Inc | [2017-06-09] |
| Roche Holding Ltd | Senseonics Holdings Inc | [2017-02-07] |
| Roche Holding Ltd | Avexis Inc | [2017-02-07] |
| Roche Holding Ltd | Foundation Medicine Inc | [2015-01-21] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Amplitude Healthcare Acquisition Corp JSPR
Voting Common Stock
|
2023-01-25 | Sell | 75,000 | $1.89 | 141,750 |
|
Entrada Therapeutics Inc TRDA
Common Stock
|
2021-11-02 | Conversion | 2,495,385 | ||
|
Entrada Therapeutics Inc TRDA
Common Stock
|
2021-11-02 | Conversion | 318,140 | ||
|
Entrada Therapeutics Inc TRDA
Series B Preferred Stock · derivative
|
2021-11-02 | Conversion | 318,140 | $0.00 | |
|
Entrada Therapeutics Inc TRDA
Series A Preferred Stock · derivative
|
2021-11-02 | Conversion | 2,495,385 | $0.00 | |
|
Pandion Therapeutics Inc PAND
Common Stock
|
2020-07-21 | Buy | 36,111 | $18.00 | 649,998 |
|
Pandion Therapeutics Inc PAND
Common Stock
|
2020-07-21 | Conversion | 3,049,973 | ||
|
Pandion Therapeutics Inc PAND
Series B Preferred Stock · derivative
|
2020-07-21 | Conversion | 2,414,098 | $0.00 | |
|
Pandion Therapeutics Inc PAND
Series A Preferred Stock · derivative
|
2020-07-21 | Conversion | 13,138,905 | $0.00 | |
|
Foundation Medicine Inc FMI
Common Stock
|
2018-07-31 | Buy | 2,343,078 | $137.00 | 321,001,686 |
|
Foundation Medicine Inc FMI
Common Stock
|
2018-07-31 | Buy | 13,877,949 | $137.00 | 1,901,279,013 |
|
Allakos Inc ALLK
Series B Preferrred Stock · derivative
|
2018-07-23 | Conversion | 502,632 | $0.00 | |
|
Allakos Inc ALLK
Series A Preferrred Stock · derivative
|
2018-07-23 | Conversion | 4,108,091 | $0.00 | |
|
Allakos Inc ALLK
Common Stock
|
2018-07-23 | Conversion | 4,610,723 | ||
|
Rein Therapeutics Inc ALRN
Common Stock
|
2017-07-05 | Buy | 119,400 | $15.00 | 1,791,000 |
|
Rein Therapeutics Inc ALRN
Common Stock
|
2017-07-05 | Conversion | 579,093 | ||
|
Rein Therapeutics Inc ALRN
Series E-2 Preferred Stock · derivative
|
2017-07-05 | Conversion | 735,775 | $0.00 | |
|
Rein Therapeutics Inc ALRN
Series F Preferred Stock · derivative
|
2017-07-05 | Conversion | 989,594 | $0.00 | |
|
Rein Therapeutics Inc ALRN
Series E-3 Preferred Stock · derivative
|
2017-07-05 | Conversion | 638,194 | $0.00 | |
|
Rein Therapeutics Inc ALRN
Series D Preferred Stock · derivative
|
2017-07-05 | Conversion | 3,390,885 | $0.00 | |
| showing 20 of 22 most recent transactions | |||||